The global market for Vascular Screening Devices was valued at US$1.7 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing at a CAGR of 4.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Vascular Screening Devices market.
The increased incidence of lifestyle-related risk factors-including diabetes, hypertension, and obesity-has amplified the role of vascular screening in both primary care and specialist clinics. Demand is also being fueled by employer-sponsored health screenings, government-led chronic disease programs, and direct-to-consumer wellness initiatives. Patients aged over 50, particularly men and post-menopausal women, form the primary demographic undergoing carotid artery and peripheral vascular screening. By identifying vascular irregularities early, these devices help stratify patients by risk, guide preventive therapies, and reduce long-term healthcare costs tied to acute cardiac events.
The integration of vascular screening into digital health platforms is also transforming follow-up care and patient engagement. Devices now interface with cloud-based patient records, enabling clinicians to track vascular health longitudinally, compare results, and guide medication adherence or lifestyle modifications. Wearable tech is emerging as an adjunct tool, with companies developing PPG-based devices that monitor vascular tone and pulse waveform irregularities in real time. Moreover, AI-powered diagnostics and risk stratification models are increasing the predictive accuracy of vascular screening, allowing health systems to triage patients more effectively and personalize care pathways.
In Asia-Pacific, rising healthcare awareness and improving diagnostic infrastructure are contributing to accelerated adoption. Countries such as Japan, South Korea, India, and China are experiencing increased deployment of vascular screening tools in urban clinics and telemedicine networks. Middle Eastern healthcare systems are also integrating such devices into diabetes and hypertension management programs, especially in Gulf countries with high CVD burden. NGOs and government health missions in Africa and Latin America are introducing portable vascular screening tools in community health camps, often supported by donor agencies and mobile health platforms.
Technological convergence-combining imaging, artificial intelligence, and mobile health-is expanding the applicability of vascular screening beyond hospitals into community settings and home care. Regulatory approvals and standardization efforts are also strengthening clinician confidence and reimbursement potential, particularly for ABI and carotid ultrasound tools. With consumer interest in health monitoring at an all-time high, and wearable innovation on the rise, vascular screening is poised to become a routine part of wellness management. Combined with policy shifts toward value-based care, these dynamics ensure sustained global growth for the vascular screening devices market in the years ahead.
Global Vascular Screening Devices Market - Key Trends & Drivers Summarized
Why Are Vascular Screening Devices Becoming Central to Preventive Cardiovascular Care?
Vascular screening devices are gaining rapid adoption as public health systems pivot toward early detection and intervention in cardiovascular disease (CVD), the leading cause of mortality globally. These devices are used to non-invasively assess the presence of vascular abnormalities such as arterial stiffness, plaque buildup, and reduced blood flow-conditions often preceding strokes, heart attacks, and peripheral artery disease (PAD). Technologies include portable Doppler ultrasound systems, pulse wave velocity analyzers, ankle-brachial index (ABI) systems, and photoplethysmography tools that enable fast, point-of-care assessments.The increased incidence of lifestyle-related risk factors-including diabetes, hypertension, and obesity-has amplified the role of vascular screening in both primary care and specialist clinics. Demand is also being fueled by employer-sponsored health screenings, government-led chronic disease programs, and direct-to-consumer wellness initiatives. Patients aged over 50, particularly men and post-menopausal women, form the primary demographic undergoing carotid artery and peripheral vascular screening. By identifying vascular irregularities early, these devices help stratify patients by risk, guide preventive therapies, and reduce long-term healthcare costs tied to acute cardiac events.
How Are Innovations in Device Design and Functionality Expanding Market Reach?
Technology is playing a pivotal role in transforming vascular screening from a specialist function into a routine diagnostic. New devices are smaller, faster, and designed for use by non-specialists. Handheld ultrasound scanners with AI-assisted image interpretation are enabling general practitioners and nurse practitioners to screen patients in primary care settings. ABI measurement tools with automated cuff inflation and built-in interpretation algorithms are being deployed in pharmacies and mobile clinics, expanding accessibility for at-risk populations in rural and underserved areas.The integration of vascular screening into digital health platforms is also transforming follow-up care and patient engagement. Devices now interface with cloud-based patient records, enabling clinicians to track vascular health longitudinally, compare results, and guide medication adherence or lifestyle modifications. Wearable tech is emerging as an adjunct tool, with companies developing PPG-based devices that monitor vascular tone and pulse waveform irregularities in real time. Moreover, AI-powered diagnostics and risk stratification models are increasing the predictive accuracy of vascular screening, allowing health systems to triage patients more effectively and personalize care pathways.
Where Is Demand for Vascular Screening Accelerating Most Rapidly?
The demand for vascular screening devices is strongest in North America and Europe, where health systems are heavily focused on CVD prevention and chronic disease management. The U.S. market benefits from a high prevalence of private health check programs and value-based reimbursement models that reward early detection. In Europe, national screening initiatives for PAD and atrial fibrillation have created robust demand for point-of-care vascular diagnostics. Additionally, aging populations across the EU are driving consistent demand for non-invasive vascular health monitoring tools in both ambulatory and home settings.In Asia-Pacific, rising healthcare awareness and improving diagnostic infrastructure are contributing to accelerated adoption. Countries such as Japan, South Korea, India, and China are experiencing increased deployment of vascular screening tools in urban clinics and telemedicine networks. Middle Eastern healthcare systems are also integrating such devices into diabetes and hypertension management programs, especially in Gulf countries with high CVD burden. NGOs and government health missions in Africa and Latin America are introducing portable vascular screening tools in community health camps, often supported by donor agencies and mobile health platforms.
What Is Fueling the Growth of the Global Vascular Screening Devices Market?
The growth in the vascular screening devices market is driven by several factors, including the rising global burden of cardiovascular disease, the shift toward preventive healthcare, and the increasing accessibility of point-of-care diagnostics. As healthcare systems seek to reduce hospitalization rates and long-term care costs, screening tools that can detect vascular anomalies early are gaining strategic importance. The proliferation of ambulatory care centers, mobile health units, and employer-based wellness programs is further enhancing distribution and utilization of these devices.Technological convergence-combining imaging, artificial intelligence, and mobile health-is expanding the applicability of vascular screening beyond hospitals into community settings and home care. Regulatory approvals and standardization efforts are also strengthening clinician confidence and reimbursement potential, particularly for ABI and carotid ultrasound tools. With consumer interest in health monitoring at an all-time high, and wearable innovation on the rise, vascular screening is poised to become a routine part of wellness management. Combined with policy shifts toward value-based care, these dynamics ensure sustained global growth for the vascular screening devices market in the years ahead.
Scope of the Report
The report analyzes the Vascular Screening Devices market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below:- Segments: Product Type (Portable Vascular Screening Devices, Standalone Vascular Screening Devices); End-User (Hospitals End-User, Diagnostic Centers / Clinics End-User, Other End-Users).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Portable Vascular Screening Devices segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 4.9%. The Standalone Vascular Screening Devices segment is also set to grow at 2.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $458.9 Million in 2024, and China, forecasted to grow at an impressive 7.8% CAGR to reach $444.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Vascular Screening Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Screening Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Vascular Screening Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as CorVascular Diagnostics, Toshiba (Canon Medical), AngioScreen (Angiology Corp. of America), BD (Becton Dickinson), Biotronik and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 42 companies featured in this Vascular Screening Devices market report include:
- CorVascular Diagnostics
- Toshiba (Canon Medical)
- AngioScreen (Angiology Corp. of America)
- BD (Becton Dickinson)
- Biotronik
- Boston Scientific
- Cardinal Health
- Abbott (Cardiovascular Diagnostic)
- FUKUDA Denshi
- GE HealthCare (Vivid Cardiovascular)
- LeMaitre Vascular
- Life Line Screening
- Medtronic
- Shenzhen Mindray Bio-Medical Electronics
- Mindray
- OMRON
- Probo Medical
- Siemens Healthineers
- Terumo
- Unetixs Vascular
This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis from 2015 to 2023.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025 (E), competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- CorVascular Diagnostics
- Toshiba (Canon Medical)
- AngioScreen (Angiology Corp. of America)
- BD (Becton Dickinson)
- Biotronik
- Boston Scientific
- Cardinal Health
- Abbott (Cardiovascular Diagnostic)
- FUKUDA Denshi
- GE HealthCare (Vivid Cardiovascular)
- LeMaitre Vascular
- Life Line Screening
- Medtronic
- Shenzhen Mindray Bio-Medical Electronics
- Mindray
- OMRON
- Probo Medical
- Siemens Healthineers
- Terumo
- Unetixs Vascular
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 276 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.7 Billion |
| Forecasted Market Value ( USD | $ 2.2 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
